Drs. Emil Lou and Tim Starr from the University of Minnesota discuss the TIL trial for metastatic CRC in this DocTalk, recorded in March, 2021 for COLONTOWN.
Dr. Starr opens this discussion with a look at the science behind the trial, including CRISPR, the powerful gene editing tool, and the tumor infiltrating lymphocytes (TILs) that give this trial its name. The second half of the video features Dr. Lou discussing the trial itself.